Honoring our roots, caring for our community.

Investigational · not FDA-approved

Semax: research, limits and regulatory status

Educational information about a synthetic peptide studied mainly in Russia. It is not FDA-approved, and its cognitive benefits are not established.

Evidence-based care Individualized plan
Semax

Introduction

Semax: what is known and what is not

Semax is a synthetic peptide studied mainly in Russia for brain-related conditions. This page explains its background, the research behind it, its limitations and its status in the United States.

Semax is not an FDA-approved medicine, and its benefits for memory or focus have not been established in well-designed studies. If you have concerns about memory, concentration or fatigue, a medical evaluation helps find the cause.

Overview

What is Semax?

Semax is a synthetic peptide of seven amino acids. It is based on a short fragment of ACTH (adrenocorticotropic hormone), modified so that it does not act like the hormone itself.

Background

Origin and research background

Semax was developed in Russia, where it is registered for certain neurological uses. Most of the published research comes from Russian research groups, and it has not been evaluated by the FDA.

Mechanisms

Proposed mechanisms

These mechanisms come mainly from laboratory and animal studies.

Brain growth factors

Studied for effects on BDNF, a protein involved in nerve cell function.

Brain chemical signals

Proposed effects on dopamine and serotonin systems.

Response to injury

Explored in animal models of reduced blood flow to the brain.

Next step

Talk with a provider first

If you have concerns about memory, focus or fatigue, a medical evaluation helps find the cause and proven options.

Request medical information

Research

Research on cognitive function

Semax has been studied for attention and memory in animals and in small human studies, and for recovery after stroke in clinical studies conducted mainly in Russia. These studies were small, often lacked independent replication and do not show that Semax improves memory or focus in healthy people.

Evidence

Available clinical evidence and its limitations

Small studies

Few participants and short follow-up.

Limited independent replication

Most results come from the same research groups.

Few controlled trials

Large, well-designed trials are lacking.

Unknown long-term effects

Long-term safety has not been studied.

Experimental vs. proven

Experimental results versus proven medical indications

A proven medical indication requires well-designed trials reviewed by a regulatory agency, such as the FDA. Semax has no FDA-approved indication: laboratory, animal and small human results suggest areas for research, not treatments with established benefits.

Regulatory status

Regulatory status in the United States

Semax is not approved by the FDA for any use. The FDA has raised safety concerns about its use in compounded drugs, and its eligibility for compounding was under review in 2026. An advisory committee recommendation is not an FDA approval.

Risks

Risks and possible side effects

Side effects have not been well characterized in large studies.

Headache

Reported in small studies.

Nasal irritation

Reported with nasal products.

Dizziness

Reported in small studies.

Irritability or anxiety

Possible changes in mood.

Trouble sleeping

Possible changes in sleep.

Unknown long-term effects

Not studied.

Safety

Contraindications, precautions and uncertainties

Because Semax has not been studied in large trials, its interactions with medicines and its safety in many groups are unknown. It may not be appropriate if any of the following apply to you:

  • Pregnancy or breastfeeding (consult your provider)
  • History of seizures or epilepsy
  • Active severe anxiety, mania or psychosis
  • Allergy to any ingredient
  • Children and adolescents under 18
  • Medicines that act on the brain — Such as antidepressants or stimulants; interactions are unknown.

Evaluation

Considerations for a medical evaluation

01

Your symptoms and history

Memory, focus, sleep, mood and medications.

02

Looking for a cause

Conditions such as thyroid problems, sleep disorders or depression.

03

Proven options

Diagnosed conditions are treated with established care.

FAQ

Semax FAQs

Clear answers to help you prepare.

No. Semax is not approved by the FDA for any use. It is registered in Russia for certain neurological uses.

This has not been established in well-designed studies, especially in healthy people. If you notice changes in memory or focus, a medical evaluation should come first.

It is not an approved treatment for any neurological disease in the United States. Neurological conditions need evaluation and treatment with established care.

Its safety has not been established in large studies, and its long-term effects and interactions with medicines are unknown.

This page is educational. It does not give doses, schedules or instructions; any decision about a medicine is made only by a licensed provider after an individual evaluation.

Information on this page is educational and does not replace medical evaluation. Treatment options are determined individually.